NSE: EMCURE
EMCURE PHARMACEUTICALS L
Price history
+11.99% over 3M
Performance
52-week range
Position in day range
EMCURE stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Uptrend
50-DMA ₹1,885.82
RSI (14)
59
Neutral momentum
Volatility (ATR)
2.42%
Moderate
Close streak
2d down
Volume vs 20d avg
1.93x
Unusual activity
From 52W high
-4.16%
Up from 52W low
+55.78%
Green days (20)
7/20
Monthly seasonality
Average monthly move for EMCURE across the available price history.
Key statistics
Open
1,926.1
Day high
1,988
Day low
1,914.5
Prev close
1,962.8
Volume
2.49 L
Avg vol (20d)
1.29 L
52W high
2,048
52W low
1,260
EMCURE quarterly results
All EMCURE results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹2,580 cr
+22.8% YoY
Net profit
₹294 cr
+42.1% YoY
Operating profit
₹398 cr
+30.9% YoY
EPS
₹15.50
+41.9% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹2,580 cr | ₹398 cr | ₹294 cr | 15.4% | 11.4% | ₹15.50 | +42.1% | +20.8% |
| Q4 FY262026-03-31 | ₹2,470 cr | ₹379 cr | ₹243 cr | 15.4% | 9.9% | ₹12.84 | — | +5.6% |
| Q3 FY262025-12-31 | ₹2,363 cr | ₹355 cr | ₹231 cr | 15.0% | 9.8% | ₹12.16 | — | -5.3% |
| Q2 FY262025-09-30 | ₹2,270 cr | ₹334 cr | ₹243 cr | 14.7% | 10.7% | ₹12.85 | — | +17.6% |
| Q1 FY262025-06-30 | ₹2,101 cr | ₹304 cr | ₹207 cr | 14.5% | 9.9% | ₹10.92 | — | — |
| TTM (last 4 quarters) | ₹9,683 cr | ₹1,468 cr | ₹1,011 cr | 15.2% | 10.4% | ₹53.35 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
Latest market news
Canara Hsbc Life Ins Share Price Opens Gap-Down at ₹149.40: What Is Driving CANHLIFE Today, and the Levels That Matter
Canara Hsbc Life Ins (CANHLIFE) trades at ₹152.36, +2.87 (+1.88%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
IPOs Leads the Morning Market Talk on 11 September 2026, Policy And Macro Data and Mutual Funds Close Behind
The most-covered market themes in the morning session on 11 September 2026 — IPOs, policy and macro data, mutual funds — with our live numbers for each and links to the publishers running the story.
Vodafone Idea Share Price Drops 4.16% to ₹14.90: What Is Driving IDEA Today, and the Levels That Matter
Vodafone Idea (IDEA) trades at ₹14.90, -0.62 (-4.16%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Novartis India Share Price Hits 52-Week High, Up 9.96%: What Is Driving NOVARTIND Today, and the Levels That Matter
Novartis India (NOVARTIND) trades at ₹2,428.20, +241.80 (+9.96%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
NEPHROPLUS in Focus: Nephrocare Health Serv Share Price Opens Gap-Down at ₹733.10 on Rising Newsflow
Nephrocare Health Serv (NEPHROPLUS) trades at ₹747.25, +13.80 (+1.85%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Fino Payments Bank Opens Gap-Down at ₹137.90 — Should Investors Read This as a Trend or a One-Day Move?
Fino Payments Bank (FINOPB) trades at ₹139.65, +2.01 (+1.44%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Price and history data from NSE via Upstox. For information only, not investment advice.